Form 4 for CATX Perspective Therapeutics, Inc.
Accepted 2023-12-26 00:00:00 ET · period of report 2023-12-21 · accession 0001437749-23-035321 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2023-12-26 | 2023-12-21 | CATX | Williamson Robert F III | Dir | P - Purchase | $0.33 | +3,663 | 3,663 | New | +$1,209 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-21 | P | A | 3,663 | $0.33 | 3,663 | I By RFW3 Revocable Trust | — | — | (F1) This price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.3249 to $0.3300, inclusive. The reporting person undertakes to provide to Perspective Therapeutics, Inc., any security holder of Perspective Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4. |